FDA Budget Reaffirms Commitment To OTCs, Reduces Supplement Programs
This article was originally published in The Tan Sheet
Executive Summary
FDA hopes to increase the number of over-the-counter drugs on the market as part of its long-term goal to provide consumers with safe, effective and affordable drugs, the agency states in its fiscal year 2007 budget request presentation
You may also be interested in...
DuPont Changing Labels For Antiseptic Products To Comply With FDA Warning
DuPont plans by the end of June to comply with FDA's warning to change the labels for its RelyOn antiseptic spray and hand-wipe products that include disease claims not approved in a pending monograph for OTC health care antiseptics or in the topical antifungal drug products monograph
DuPont Changing Labels For Antiseptic Products To Comply With FDA Warning
DuPont plans by the end of June to comply with FDA's warning to change the labels for its RelyOn antiseptic spray and hand-wipe products that include disease claims not approved in a pending monograph for OTC health care antiseptics or in the topical antifungal drug products monograph
DuPont Changing Labels For Antiseptic Products To Comply With FDA Warning
DuPont plans by the end of June to comply with FDA's warning to change the labels for its RelyOn antiseptic spray and hand-wipe products that include disease claims not approved in a pending monograph for OTC health care antiseptics or in the topical antifungal drug products monograph